BTG2 and cancer: Several studies have reported that BTG2 expression is downregulated in some cancers, including laryngeal carcinoma (Liu et al., 2009), pancreatic cancer (Coppola et al., 2013) and renal cell carcinoma (Struckmann et al., 2004).